The effects of post-exposure smallpox vaccination on clinical disease presentation: Addressing the data gaps between historical epidemiology and modern surrogate model data

Vaccine

Volumn 31, Issue 45, 2013, Pages 5192-5201

  Keckler, M Shannon ^a   Reynolds, Mary G ^a   Damon, Inger K ^a   Karem, Kevin L ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

Animal models; Epidemiology; Monkeypox; Orthopoxviruses; Post exposure vaccination; Prophylactic vaccination; Smallpox; Smallpox vaccination; Vaccinia; Variola virus

Indexed keywords

SMALLPOX VACCINE; VACCINIA VACCINE;

ADAPTIVE IMMUNITY; CLINICAL FEATURE; DATA ANALYSIS; DRUG EFFICACY; DRUG EXPOSURE; DRUG SAFETY; EPIDEMIC; HEALTH CARE POLICY; HISTORICAL PERIOD; HUMAN; IMMUNE RESPONSE; INFECTION CONTROL; INNATE IMMUNITY; MONKEYPOX VIRUS; MORBIDITY; MORTALITY; NONHUMAN; ORTHOPOXVIRUS; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW; SMALLPOX; SMALLPOX VIRUS; VACCINATION;

ANIMAL MODELS; EPIDEMIOLOGY; MONKEYPOX; ORTHOPOXVIRUSES; POST-EXPOSURE VACCINATION; PROPHYLACTIC VACCINATION; SMALLPOX; SMALLPOX VACCINATION; VACCINIA; VARIOLA VIRUS;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; POST-EXPOSURE PROPHYLAXIS; SMALLPOX; SMALLPOX VACCINE; VACCINATION;

EID: 84885952698     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.08.039     Document Type: Review

References (96)

1. Liceaga E. The Jenner vaccine well preserved and carefully propagated is a permanent preservative against smallpox. Public Health Pap Rep 1900, 26:92-97.
2. Garciadiego S. The only certain prophylaxis against smallpox is human vaccine which, if well inoculated, does not transmit infectious-contagious nor diathetic disease. Public Health Pap Rep 1900, 26:84-86.
3. Henderson D.A. Smallpox eradication. Public Health Rep 1980, 95(5):422-426.
4. Irons J.V., Sullivan T.D., Cook E.B., Cox G.W., Hale R.A. Outbreak of smallpox in the lower Rio Grande Valley of Texas in 1949. Am J Public Health Nations Health 1953, 43(1):25-29.
5. Top F.H., Peck L.E. A small outbreak of smallpox in Detroit. Am J Public Health Nations Health 1943, 33(5):490-498.
6. Foege W.H., Millar J.D., Lane J.M. Selective epidemiologic control in smallpox eradication. Am J Epidemiol 1971, 94(4):311-315.
7. Henderson D.A. Epidemiology in the global eradication of smallpox. Int J Epidemiol 1972, 1(1):25-30.
8. Lane J.M., Millar J.D., Neff J.M. Smallpox and smallpox vaccination policy. Annu Rev Med 1971, 22:251-272.
9. Beardmore W.B. A new form of smallpox vaccine. J Infect Dis 1973, 127(6):718-719.
10. Hooper J.W., Custer D.M., Thompson E. Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates. Virology 2003, 306(1):181-195.
11. Golden J.W., Hooper J.W. The strategic use of novel smallpox vaccines in the post-eradication world. Expert Rev Vaccines 2011, 10(7):1021-1035.
12. United States Food and Drug Administration (FDA) The development and evaluation of next-generation smallpox vaccines - transcript of meeting held Friday 2011.
13. Wharton M., Strikas R.A., Harpaz R., Rotz L.D., Schwartz B., Casey C.G., et al. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 2003, 52(RR-7):1-16.
14. Sankar P., Schairer C., Coffin S. Public mistrust: the unrecognized risk of the CDC Smallpox Vaccination Program. Am J Bioeth 2003, 3(4):W22-W25.
15. Amorosa V.K., Isaacs S.N. Separate worlds set to collide: smallpox, vaccinia virus vaccination, and human immunodeficiency virus and acquired immunodeficiency syndrome. Clin Infect Dis 2003, 37(3):426-432.
16. Breman J.G., Arita I. The confirmation and maintenance of smallpox eradication. N Engl J Med 1980, 303(22):1263-1273.
17. Breman J.G., Kalisa R., Steniowski M.V., Zanotto E., Gromyko A.I., Arita I. Human monkeypox: 1970-79. Bull World Health Organ 1980, 58(2):165-182.
18. Rimoin A.W., Mulembakani P.M., Johnston S.C., Lloyd Smith J.O., Kisalu N.K., Kinkela T.L., et al. Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. Proc Natl Acad Sci U S A 2010, 107(37):16262-16267.
19. Reynolds M.G., Damon I.K. Outbreaks of human monkeypox after cessation of smallpox vaccination. Trends Microbiol 2012, 20(2):80-87.
20. Megid J., Borges I.A., Abrahao J.S., Trindade G.S., Appolinario C.M., Ribeiro M.G., et al. Vaccinia virus zoonotic infection: Sao Paulo State, Brazil. Emerg Infect Dis 2012, 18(1):189-191.
21. Vogel S., Sardy M., Glos K., Korting H.C., Ruzicka T., Wollenberg A. The Munich outbreak of cutaneous cowpox infection: transmission by infected pet rats. Acta Derm Venereol 2012, 92(2):126-131.
22. Gurav Y.K., Raut C.G., Yadav P.D., Tandale B.V., Sivaram A., Pore M.D., et al. Buffalopox outbreak in humans and animals in Western Maharashtra, India. Prev Vet Med 2011, 100(3-4):242-247.
23. Salzer J.S., Carroll D.S., Rwego I.B., Li Y., Falendysz E.A., Shisler J.L., et al. Serologic evidence for circulating orthopoxviruses in peridomestic rodents from rural Uganda. J Wildl Dis 2013, 49(1):125-131.
24. Gallardo-Romero N.F., Drew C.P., Weiss S.L., Metcalfe M.G., Nakazawa Y.J., Smith S.K., et al. The pox in the North American backyard: Volepox virus pathogenesis in California mice (Peromyscus californicus). PLoS ONE 2012, 7(8):e43881.
25. Mota B.E., Trindade G.S., Diniz T.C., da Silva-Nunes M., Braga E.M., Urbano-Ferreira M., et al. Seroprevalence of orthopoxvirus in an Amazonian rural village: Acre, Brazil. Arch Virol 2010, 155(7):1139-1144.
26. Tucker J.B. Breaking the deadlock over destruction of the smallpox virus stocks. Biosecur Bioterror 2011, 9(1):55-67.
27. Henderson D.A. Principles and lessons from the smallpox eradication programme. Bull World Health Organ 1987, 65(4):535-546.
28. Lane J.M. Remaining questions about clinical variola major. Emerg Infect Dis 2011, 17(4):676-680.
29. Chapman J.L., Nichols D.K., Martinez M.J., Raymond J.W. Animal models of orthopoxvirus infection. Vet Pathol 2010, 47(5):852-870.
30. Crosby D. Epidemic of Smallpox. Cal State J Med 1904, 2(4):110-113.
31. Sutherland I.N. Some aspects of the epidemiology of smallpox in Scotland in 1942. Proc R Soc Med 1943, 36(5):227-236. [Abridged.].
32. Dixon C.W. Smallpox in Tripolitania: 1946; an epidemiological and clinical study of 500 cases, including trials of penicillin treatment. J Hyg (Lond) 1948, 46(4):351-377.
33. Smith C.S. Smallpox in Staffordshire: 1947; outbreak at Bilston. Br Med J 1948, 1(4542):139-142.
34. Mack T.M. Smallpox in Europe: 1950-1971. J Infect Dis 1972, 125(2):161-169.
35. Rao A.R. Smallpox 1972, 220. Kothari Book Depot, Bombay. 1st ed.
36. Douglas J., Edgar W. Smallpox in Bradford: 1962. Br Med J 1962, 1(5278):612-614.
37. Rao A.R., Jacob E.S., Kamalakshi S., Appaswamy S., Bradbury Epidemiological studies in smallpox. A study of intrafamilial transmission in a series of 254 infected families. Indian J Med Res 1968, 56(12):1826-1854.
38. Mack T.M., Thomas D.B., Ali A., Muzaffar Khan M. Epidemiology of smallpox in West Pakistan I. Acquired immunity and the distribution of disease. Am J Epidemiol 1972, 95(2):157-168.
39. Heiner G.G., Fatima N., McCrumb F.R. A study of intrafamilial transmission of smallpox. Am J Epidemiol 1971, 94(4):316-326.
40. Sommer A. The 1972 smallpox outbreak in Khulna Municipality: Bangladesh II. Effectiveness of surveillance and containment in urban epidemic control. Am J Epidemiol 1974, 99(4):303-313.
41. Mazumder D.N., Chakraborty A.K. Epidemic of smallpox among the evacuees from Bangladesh in Salt Lake area near Calcutta. J Indian Med Assoc 1973, 60(8):275-280.
42. Mazumder D.N., Mitra A.C., Mukherjee M.K. Clinical observations on smallpox: a study of 1233 patients admitted to the Infectious Diseases Hospital, Calcutta, during 1973. Bull World Health Organ 1975, 52(3):301-306.
43. Bauer, Letter D.J. Vaccination of smallpox contacts. Br Med J 1974, 1(5907):576.
44. McClean D. The use of smallpox vaccine. Bull World Health Organ 1955, 13(3):437-446.
45. Massoudi M.S., Barker L., Schwartz B. Effectiveness of postexposure vaccination for the prevention of smallpox: results of a delphi analysis. J Infect Dis 2003, 188(7):973-976.
46. Mortimer P.P. Can postexposure vaccination against smallpox succeed?. Clin Infect Dis 2003, 36(5):622-629.
47. Krag P., Bentzon M.W. The international reference preparation of smallpox vaccine. An international collaborative assay. Bull World Health Organ 1963, 29:299-309.
48. Regamey R.H., Cohen H.H., International Association of Biological Standardization Proceedings of the 37th symposium organized by the International Association of Biological Standardization and held at the Rijks Instituut voor de Volksgezondheid 1973, Basel, New York, S. Karger, xii, 365 p.
49. Stittelaar K.J., Neyts J., Naesens L., van Amerongen G., van Lavieren R.F., Holy A., et al. Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection. Nature 2006, 439(7077):745-748.
50. Staib C., Suezer Y., Kisling S., Kalinke U., Sutter G. Short-term, but not post-exposure, protection against lethal orthopoxvirus challenge after immunization with modified vaccinia virus Ankara. J Gen Virol 2006, 87(Pt 10):2917-2921.
51. Paran N., Suezer Y., Lustig S., Israely T., Schwantes A., Melamed S., et al. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox. J Infect Dis 2009, 199(1):39-48.
52. Lauterbach H., Kassub R., Patzold J., Korner J., Bruckel M., Verschoor A., et al. Immune requirements of post-exposure immunization with modified vaccinia Ankara of lethally infected mice. PLoS ONE 2010, 5(3):e9659.
53. Samuelsson C., Hausmann J., Lauterbach H., Schmidt M., Akira S., Wagner H., et al. Survival of lethal poxvirus infection in mice depends on TLR9: and therapeutic vaccination provides protection. J Clin Invest 2008, 118(5):1776-1784.
54. Essbauer S., Pfeffer M., Meyer H. Zoonotic poxviruses. Vet Microbiol 2010, 140(3-4):229-236.
55. Jones T.C. The value of animal models. Am J Pathol 1980, 101(3 Suppl):S3-S9.
56. Brinckerhoff W.R., Tyzzer E.E. Studies upon the immunity reactions of the monkey after inoculation with vaccine or with variola virus: part III. J Med Res 1906, 14(2):321-339.
57. Nelson J.B. The behavior of pox viruses in the respiratory tract: II. The response of mice to the nasal instillation of variola virus. J Exp Med 1939, 70(1):107-116.
58. Hanna K.E. Extraordinary measures for countermeasures to terrorism: FDA's "Animal Rule". Hastings Cent Rep 2002, 32(4):9.
59. Lofquist J.M., Weimert N.A., Hayney M.S. Smallpox: a review of clinical disease and vaccination. Am J Health Syst Pharm 2003, 60(8):749-756. [quiz 757-8].
60. Rodrigues-Da-Silva G., Angulo J.J., Rabello S.I. Clinical types of smallpox as seen in an epidemic. Postgrad Med J 1962, 38:140-144.
61. Breman J.G., Henderson D.A. Diagnosis and management of smallpox. N Engl J Med 2002, 346(17):1300-1308.
62. Westwood J.C., Boulter E.A., Bowen E.T., Maber H.B. Experimental respiratory infection with poxviruses I. Clinical virological and epidemiological studies. Br J Exp Pathol 1966, 47(5):453-465.
63. LeDuc J.W., Jahrling P.B. Strengthening national preparedness for smallpox: an update. Emerg Infect Dis 2001, 7(1):155-157.
64. Zaucha G.M., Jahrling P.B., Geisbert T.W., Swearengen J.R., Hensley L. The pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (Macaca fascicularis). Lab Invest 2001, 81(12):1581-1600.
65. Goff A.J., Chapman J., Foster C., Wlazlowski C., Shamblin J., Lin K., et al. A novel respiratory model of infection with monkeypox virus in cynomolgus macaques. J Virol 2011, 85(10):4898-4909.
66. Parker S., Siddiqui A.M., Painter G., Schriewer J., Buller R.M. Ectromelia virus infections of mice as a model to support the licensure of anti-orthopoxvirus therapeutics. Viruses 2010, 2(9):1918-1932.
67. Parker S., Siddiqui A.M., Oberle C., Hembrador E., Lanier R., Painter G., et al. Mousepox in the C57BL/6 strain provides an improved model for evaluating anti-poxvirus therapies. Virology 2009, 385(1):11-21.
68. Fenner F. Mouse-pox; infectious ectromelia of mice; a review. J Immunol 1949, 63(4):341-373.
69. Schriewer J., Buller R.M., Owens G. Mouse models for studying orthopoxvirus respiratory infections. Methods Mol Biol 2004, 269:289-308.
70. Americo J.L., Moss B., Earl P.L. Identification of wild-derived inbred mouse strains highly susceptible to monkeypox virus infection for use as small animal models. J Virol 2010, 84(16):8172-8180.
71. Earl P.L., Americo J.L., Moss B. Lethal monkeypox virus infection of CAST/EiJ mice is associated with a deficient gamma interferon response. J Virol 2012, 86(17):9105-9112.
72. Sbrana E., Jordan R., Hruby D.E., Mateo R.I., Xiao S.Y., Siirin M., et al. Efficacy of the antipoxvirus compound ST-246 for treatment of severe orthopoxvirus infection. Am J Trop Med Hyg 2007, 76(4):768-773.
73. Tesh R.B., Watts D.M., Sbrana E., Siirin M., Popov V.L., Xiao S.Y. Experimental infection of ground squirrels (Spermophilus tridecemlineatus) with monkeypox virus. Emerg Infect Dis 2004, 10(9):1563-1567.
74. Hutson C.L., Carroll D.S., Gallardo-Romero N., Weiss S., Clemmons C., Hughes C.M., et al. Monkeypox disease transmission in an experimental setting: prairie dog animal model. PLoS ONE 2011, 6(12):pe28295.
75. Hutson C.L., Carroll D.S., Self J., Weiss S., Hughes C.M., Braden Z., et al. Dosage comparison of Congo Basin and West African strains of monkeypox virus using a prairie dog animal model of systemic orthopoxvirus disease. Virology 2010, 402(1):72-82.
76. Hutson C.L., Olson V.A., Carroll D.S., Abel J.A., Hughes C.M., Braden Z.H., et al. A prairie dog animal model of systemic orthopoxvirus disease using West African and Congo Basin strains of monkeypox virus. J Gen Virol 2009, 90(Pt. 2):323-333.
77. Keckler M.S., Carroll D.S., Gallardo-Romero N.F., Lash R.R., Salzer J.S., Weiss S.L., et al. Establishment of the black-tailed prairie dog (Cynomys ludovicianus) as a novel animal model for comparing smallpox vaccines administered preexposure in both high- and low-dose monkeypox virus challenges. J Virol 2011, 85(15):7683-7698.
78. Smith S.K., Self J., Weiss S., Carroll D., Braden Z., Regnery R.L., et al. Effective antiviral treatment of systemic orthopoxvirus disease: ST-246 treatment of prairie dogs infected with monkeypox virus. J Virol 2011, 85(17):9176-9187.
79. Xiao S.Y., Sbrana E., Watts D.M., Siirin M., da Rosa A.P., Tesh R.B. Experimental infection of prairie dogs with monkeypox virus. Emerg Infect Dis 2005, 11(4):539-545.
80. Garza N.L., Hatkin J.M., Livingston V., Nichols D.K., Chaplin P.J., Volkmann A., et al. Evaluation of the efficacy of modified vaccinia Ankara (MVA)/IMVAMUNE against aerosolized rabbitpox virus in a rabbit model. Vaccine 2009, 27(40):5496-5504.
81. Nalca A., Nichols D.K. Rabbitpox: a model of airborne transmission of smallpox. J Gen Virol 2011, 92(Pt. 1):31-35.
82. Jahrling P.B., Hensley L.E., Martinez M.J., Leduc J.W., Rubins K.H., Relman D.A., et al. Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox. Proc Natl Acad Sci U S A 2004, 101(42):15196-15200.
83. Kramski M.et al. A novel highly reproducible and lethal nonhuman primate model for orthopox virus infection. PLoS ONE 2010, 5(4):e10412.
84. Matz-Rensing K., Stahl-Hennig C., Kramski M., Pauli G., Ellerbrok H., Kaup F.J. The pathology of experimental poxvirus infection in common marmosets (Callithrix jacchus): further characterization of a new primate model for orthopoxvirus infections. J Comp Pathol 2012, 146(2-3):230-242.
85. Kremer M.et al. Critical role of perforin-dependent CD8+ T cell immunity for rapid protective vaccination in a murine model for human smallpox. PLoS Pathog 2012, 8(3):e1002557.
86. Haralambieva I.H., Oberg A.L., Dhiman N., Ovsyannikova I.G., Kennedy R.B., Grill D.E., et al. High-dimensional gene expression profiling studies in high and low responders to primary smallpox vaccination. J Infect Dis 2012, 206(10):1512-1520.
87. Townsend M.B., Keckler M.S., Patel N., Davies D.H., Felgner P., Damon I.K., et al. Humoral immunity to smallpox vaccines and monkeypox virus challenge: proteomic assessment and clinical correlations. J Virol 2013, 87(2):900-911.
88. Moss B. Smallpox vaccines: targets of protective immunity. Immunol Rev 2011, 239(1):8-26.
89. Hermanson G., Chun S., Felgner J., Tan X., Pablo J., Nakajima-Sasaki R., et al. Measurement of antibody responses to Modified Vaccinia virus Ankara (MVA) and Dryvax((R)) using proteome microarrays and development of recombinant protein ELISAs. Vaccine 2012, 30(3):614-625.
90. Nishiura H. Determination of the appropriate quarantine period following smallpox exposure: an objective approach using the incubation period distribution. Int J Hyg Environ Health 2009, 212(1):97-104.
91. Earl P.L., Americo J.L., Wyatt L.S., Espenshade O., Bassler J., Gong K., et al. Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus. Proc Natl Acad Sci U S A 2008, 105(31):10889-10894.
92. Hatch G.J., Graham V.A., Bewley K.R., Tree J.A., Dennis M., Taylor I., et al. Assessment of the protective effect of IMVAMUNE(R) and ACAM2000(R) vaccines against aerosolised Monkeypox virus in cynomolgus macaques. J Virol 2013.
93. Moyron-Quiroz J.E., McCausland M.M., Kageyama R., Sette A., Crotty S. The smallpox vaccine induces an early neutralizing IgM response. Vaccine 2009, 28(1):140-147.
94. Lu B., Yu W., Huang X., Wang H., Liu L., Chen Z. Mucosal immunization induces a higher level of lasting neutralizing antibody response in mice by a replication-competent smallpox vaccine: vaccinia Tiantan strain. J Biomed Biotechnol 2011, 2011:970424.
95. Kaufman D.R., Goudsmit J., Holterman L., Ewald B.A., Denholtz M., Devoy C., et al. Differential antigen requirements for protection against systemic and intranasal vaccinia virus challenges in mice. J Virol 2008, 82(14):6829-6837.
96. Aebersold P. FDA experience with medical countermeasures under the animal rule. Adv Prev Med 2012, 2012:507571.